Tribute Pharmaceuticals Reports Double Digit Revenue Growth in Third Quarter 2014
Tribute Pharmaceuticals Schedules Third Quarter 2014 Financial Results Conference Call
Tribute Pharmaceuticals Receives Uracyst® Patent in Europe